Literature DB >> 14673048

Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer.

Jürgen Weitz1, Michael D'Angelica, Mithat Gonen, David Klimstra, Daniel G Coit, Murray F Brennan, Martin S Karpeh.   

Abstract

PURPOSE: To assess the interaction of splenectomy and perioperative allogeneic blood transfusions on the prognosis of patients undergoing a potentially curative resection of proximal gastric and gastroesophageal junction (GEJ) cancer, because reports from the transplantation literature demonstrated that the immunosuppressive effects of transfusions are dependent on the presence of an intact spleen. PATIENTS AND METHODS: Between July 1, 1985, and July 30, 2001, 240 patients underwent complete resection (R0) of a proximal gastric or GEJ cancer (Siewert type II or III). Clinical and pathologic factors were collected in a prospective database. The survival data were modeled using the method of Kaplan and Meier and analyzed by the log-rank test and Cox regression.
RESULTS: The median follow-up of the patients was 25 months (40 months for survivors). The median relapse-free survival was 30 months, and the median disease-specific survival was 45 months. Univariate analysis suggested an interaction of splenectomy and perioperative transfusion in their effect on relapse-free survival. Patients who received a perioperative transfusion but did not undergo splenectomy demonstrated the worst prognosis on multivariate analysis independent of other prognostic factors. In patients who underwent splenectomy, perioperative transfusion had no effect on relapse-free survival on multivariate analysis.
CONCLUSION: Our study suggests an interaction of blood transfusion and splenectomy in their effect on survival paralleling the findings in the transplantation literature. The adverse effect of allogeneic blood transfusion on prognosis in patients with gastric cancer seems to be associated with the presence of an intact spleen and is abrogated by its absence.

Entities:  

Mesh:

Year:  2003        PMID: 14673048     DOI: 10.1200/JCO.2003.12.136

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  13 in total

1.  The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer.

Authors:  Lindsay L Morgenstern Warner; Sean C Dowdy; Janice R Martin; Maureen A Lemens; Michaela E McGree; Amy L Weaver; Karl C Podratz; Jamie N Bakkum-Gamez
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

2.  Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.

Authors:  Akira Ema; Keishi Yamashita; Shinich Sakuramoto; Guoqin Wang; Hiroaki Mieno; Masayuki Nemoto; Tomotaka Shibata; Natsuya Katada; Shiro Kikuchi; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2013-06-26       Impact factor: 7.370

3.  The paradoxical effects of splenectomy on tumor growth.

Authors:  Richmond T Prehn
Journal:  Theor Biol Med Model       Date:  2006-06-26       Impact factor: 2.432

Review 4.  [Importance of anesthesia in multimodal oncologic therapeutical concepts].

Authors:  J Weitz; M A Weigand; P Kienle; D Jäger; M W Büchler; E Martin
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

5.  Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.

Authors:  Mary E Platek; Mary E Reid; Gregory E Wilding; Wainwright Jaggernauth; Nestor R Rigual; Wesley L Hicks; Saurin R Popat; Graham W Warren; Maureen Sullivan; Wade L Thorstad; Mohamed K Khan; Thom R Loree; Anurag K Singh
Journal:  Head Neck       Date:  2010-12-15       Impact factor: 3.147

6.  Prognoses of advanced esophago-gastric junction cancer may be modified by thoracotomy and splenectomy.

Authors:  Kei Hosoda; Keishi Yamashita; Harukazu Tsuruta; Hiromitsu Moriya; Hiroaki Mieno; Akira Ema; Marie Washio; Masahiko Watanabe
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

7.  Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.

Authors:  Sam C Wang; Joanne F Chou; Vivian E Strong; Murray F Brennan; Marinela Capanu; Daniel G Coit
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

8.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

9.  Ischemic colitis: analysis of risk factors for postoperative mortality.

Authors:  Dalibor Antolovic; Moritz Koch; Ulf Hinz; Dominik Schöttler; Thomas Schmidt; Ulrike Heger; Jan Schmidt; Markus W Büchler; Jürgen Weitz
Journal:  Langenbecks Arch Surg       Date:  2008-02-20       Impact factor: 3.445

10.  Surgical resection of stage IV colorectal cancer and prognosis.

Authors:  Hiroshi Katoh; Keishi Yamashita; Yukihito Kokuba; Takeo Satoh; Heita Ozawa; Kazuhiko Hatate; Atsushi Ihara; Takatoshi Nakamura; Wataru Onosato; Masahiko Watanabe
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.